The present invention relates to novel compounds of the formula (I)
##STR00001## including all stereoisomers and tautomers thereof, to the
pharmaceutically acceptable salts and solvates thereof, to the processes
and reactive intermediates for their preparation and to their use in the
prophylaxis and treatment of asthma and other inflammatory diseases
and/or conditions in humans.